NCT/Study#
NA /
2021-0512
Clinical Efficacy And Mechanisms Of Resistance To Polatuzumab Vedotin In Patients With Large B-Cell Lymphoma After CAR T-Cell Therapy
DISEASE GROUP:
Lymphoma
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
